Barbora Paldus is an endocrinologist working at St Vincent's Hospital Melbourne in Fitzroy, VIC. She looks after people with hormone and metabolism health needs, and a big part of her day-to-day work is diabetes care.
Many of her patients live with type 1 diabetes (T1D). That can mean regular planning around insulin, meals, and day-to-day wellbeing, plus making sure blood glucose targets stay on track. At times, she also helps people through sudden changes, when things feel more urgent and harder to manage.
Low blood sugar is another key focus. Coeliac? No—sorry, diabetes only. Low blood sugar can happen fast, and it can make you feel shaky, sweaty, confused, or just “not right”. In many cases, she helps patients and families understand what may be triggering the drops, and how to respond quickly and safely when they do occur.
She also supports patients who have had diabetic ketoacidosis (DKA). DKA is serious, and it needs prompt treatment. In clinic and follow-up, the aim is to work out what happened, reduce the chance of it coming back, and give patients a practical plan they can use when things get stressful or illness hits.
Barbora’s experience is built around real-world diabetes care, where plans need to fit around work, school, sport, eating, sleep, and the everyday stuff that can’t be ignored. She understands that this kind of care is not just about numbers. It’s about confidence, routines, and staying steady when life changes.
Her medical education includes training in endocrinology and ongoing learning as treatment and technology evolve. While the details of specific qualifications and past roles aren’t listed here, her work at a major hospital in Melbourne shows she’s used to managing complex diabetes presentations, including both routine care and times when patients need help sooner rather than later.
Research and clinical trial involvement isn’t stated here, so the focus stays on the clinical side: helping patients understand what’s going on, supporting safer day-to-day management, and working towards better outcomes for people living with type 1 diabetes.
